Please assess the completion status of the following clinical trial:

Trial Title: Probiotics in Radiation-treated Gynecologic Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Women diagnosed with cancer in the small pelvis and waiting to receive radiotherapy either as a primary or as a secondary treatment following surgery. Chemotherapy may or may not be part of the treatment regimen.~* Age, older than 18 years old.~* Agreement for participation in the study by signed written informed consent.~Exclusion Criteria:~* Previously treated with irradiation of the pelvic area.~* Reluctance to refrain from using other probiotic products during the participation in the study.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Placebo (Type: PLACEBO_COMPARATOR): capsules containing corn starch
- Probiotic low dose (Type: ACTIVE_COMPARATOR): capsules containing probiotic powder and corn starch
- Probiotic high dose (Type: ACTIVE_COMPARATOR): capsules containing probiotic powder and corn starch

Based on this trial design, predict the completion outcome and termination type (if applicable).